Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial

1. Adkins, D.R.
2. Lin, J.-C.
3. Sacco, A.
4. Ley, J.
5. Oppelt, P.
6. Vanchenko, V.
7. Komashko, N.
8. Yen, C.-J.
9. Wise-Draper, T.
10. Lopez-Picazo Gonzalez, J.
11. Radulovic, S.
12. Shen, Q.
13. Thurm, H.
14. Martini, J.-F.
15. Hoffman, J.
16. Huang, X.
17. Melichar, B.
18. Tahara, M.